INFLIXIMAB (IFX) - ANVISA Registration 10350840426

Access comprehensive regulatory information for INFLIXIMAB (IFX) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840426 and manufactured by BODITECH MED INC.. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 4 companies making the same product including IMMUNDIAGNOSTIK AG, PROGENIKA BIOPHARMA S.L., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.